JEFFREY RYAN-STOUT: Open Payments
NPI 1568910602 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,239 in 128 payments from 13 companies in 2025. Trend: 2023 $2,947 · 2024 $3,610 · 2025 $2,239
Food & beverage: $2,161Education: $78
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $744 |
| Amgen Inc. | 54 | $678 |
| AstraZeneca Pharmaceuticals LP | 10 | $215 |
| UCB, Inc. | 6 | $147 |
| Novartis Pharmaceuticals Corporation | 9 | $145 |
| Janssen Biotech, Inc. | 2 | $94 |
| Organon LLC | 4 | $48 |
| PFIZER INC. | 2 | $44 |
| Fresenius Kabi USA, LLC | 1 | $31 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
Products named: RINVOQ, SAPHNELO, ENBREL, SKYRIZI, Bimzelx, COSENTYX, OTEZLA, TAVNEOS.
Industry payments across MI — which companies pay providers there.
